128 related articles for article (PubMed ID: 21550076)
1. Treatment with the α-glucosidase inhibitor miglitol from the preonset stage in Otsuka Long-Evans Tokushima Fatty rats improves glycemic control and reduces the expression of inflammatory cytokine genes in peripheral leukocytes.
Mochizuki K; Fukaya N; Tanaka Y; Fuchigami M; Goda T
Metabolism; 2011 Nov; 60(11):1560-5. PubMed ID: 21550076
[TBL] [Abstract][Full Text] [Related]
2. The alpha-glucosidase inhibitor miglitol decreases glucose fluctuations and gene expression of inflammatory cytokines induced by hyperglycemia in peripheral leukocytes.
Fukaya N; Mochizuki K; Shimada M; Goda T
Nutrition; 2009 Jun; 25(6):657-67. PubMed ID: 19216056
[TBL] [Abstract][Full Text] [Related]
3. The α-glucosidase inhibitor miglitol decreases glucose fluctuations and inflammatory cytokine gene expression in peripheral leukocytes of Japanese patients with type 2 diabetes mellitus.
Osonoi T; Saito M; Mochizuki K; Fukaya N; Muramatsu T; Inoue S; Fuchigami M; Goda T
Metabolism; 2010 Dec; 59(12):1816-22. PubMed ID: 20667563
[TBL] [Abstract][Full Text] [Related]
4. The alpha-glucosidase inhibitor miglitol delays the development of diabetes and dysfunctional insulin secretion in pancreatic beta-cells in OLETF rats.
Fukaya N; Mochizuki K; Tanaka Y; Kumazawa T; Jiuxin Z; Fuchigami M; Goda T
Eur J Pharmacol; 2009 Dec; 624(1-3):51-7. PubMed ID: 19818342
[TBL] [Abstract][Full Text] [Related]
5. Treatment with DPP-4I Anagliptin or α-GI Miglitol Reduces IGT Development and the Expression of CVD Risk Factors in OLETF Rats.
Imai C; Harazaki T; Inoue S; Mochizuki K; Goda T
J Nutr Sci Vitaminol (Tokyo); 2015; 61(4):313-21. PubMed ID: 26440638
[TBL] [Abstract][Full Text] [Related]
6. The alpha-glucosidase inhibitor miglitol suppresses postprandial hyperglycaemia and interleukin-1beta and tumour necrosis factor-alpha gene expression in rat peripheral leucocytes induced by intermittent sucrose loading.
Tanaka Y; Mochizuki K; Fukaya N; Shimada M; Goda T
Br J Nutr; 2009 Jul; 102(2):221-5. PubMed ID: 19138443
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of postprandial hyperglycemia by either an insulin-dependent or -independent drug reduces the expression of genes related to inflammation in peripheral leukocytes of OLETF rats.
Imai C; Harazaki T; Inoue S; Mochizuki K; Goda T
Biosci Biotechnol Biochem; 2013; 77(11):2305-8. PubMed ID: 24200798
[TBL] [Abstract][Full Text] [Related]
8. Design and evaluation of oral bioadhesive controlled release formulations of miglitol, intended for prolonged inhibition of intestinal alpha-glucosidases and enhancement of plasma glucagon like peptide-1 levels.
Deshpande MC; Venkateswarlu V; Babu RK; Trivedi RK
Int J Pharm; 2009 Oct; 380(1-2):16-24. PubMed ID: 19563873
[TBL] [Abstract][Full Text] [Related]
9. Effects of miglitol, an alpha-glucosidase inhibitor, on glycaemic status and histopathological changes in islets in non-obese, non-insulin-dependent diabetic Goto-Kakizaki rats.
Goda T; Suruga K; Komori A; Kuranuki S; Mochizuki K; Makita Y; Kumazawa T
Br J Nutr; 2007 Oct; 98(4):702-10. PubMed ID: 17537288
[TBL] [Abstract][Full Text] [Related]
10. The alpha-glucosidase inhibitor miglitol affects bile acid metabolism and ameliorates obesity and insulin resistance in diabetic mice.
Hamada Y; Nagasaki H; Fuchigami M; Furuta S; Seino Y; Nakamura J; Oiso Y
Metabolism; 2013 May; 62(5):734-42. PubMed ID: 23194643
[TBL] [Abstract][Full Text] [Related]
11. Changes in α-glucosidase activities along the jejunal-ileal axis of normal rats by the α-glucosidase inhibitor miglitol.
Mochizuki K; Hanai E; Suruga K; Kuranuki S; Goda T
Metabolism; 2010 Oct; 59(10):1442-7. PubMed ID: 20153003
[TBL] [Abstract][Full Text] [Related]
12. Antiobesity effects and improvement of insulin sensitivity by 1-deoxynojirimycin in animal models.
Kong WH; Oh SH; Ahn YR; Kim KW; Kim JH; Seo SW
J Agric Food Chem; 2008 Apr; 56(8):2613-9. PubMed ID: 18363357
[TBL] [Abstract][Full Text] [Related]
13. Effect of miglitol, an alpha-glucosidase inhibitor, on atherogenic outcomes in balloon-injured diabetic rats.
Hirata A; Igarashi M; Iwai H; Tominaga M
Horm Metab Res; 2009 Mar; 41(3):213-20. PubMed ID: 19085811
[TBL] [Abstract][Full Text] [Related]
14. Left-ventricular diastolic dysfunction may be prevented by chronic treatment with PPAR-alpha or -gamma agonists in a type 2 diabetic animal model.
Kim SK; Zhao ZS; Lee YJ; Lee KE; Kang SM; Choi D; Lim SK; Chung N; Lee HC; Cha BS
Diabetes Metab Res Rev; 2003; 19(6):487-93. PubMed ID: 14648808
[TBL] [Abstract][Full Text] [Related]
15. Reduced expression of β2 integrin genes in rat peripheral leukocytes by inhibiting postprandial hyperglycemia.
Mochizuki K; Shimada M; Tanaka Y; Fukaya N; Goda T
Biosci Biotechnol Biochem; 2010; 74(12):2470-4. PubMed ID: 21150098
[TBL] [Abstract][Full Text] [Related]
16. Effect of PPAR-alpha and -gamma agonist on the expression of visfatin, adiponectin, and TNF-alpha in visceral fat of OLETF rats.
Choi KC; Ryu OH; Lee KW; Kim HY; Seo JA; Kim SG; Kim NH; Choi DS; Baik SH; Choi KM
Biochem Biophys Res Commun; 2005 Oct; 336(3):747-53. PubMed ID: 16157299
[TBL] [Abstract][Full Text] [Related]
17. Dietary diacylglycerol reduces postprandial hyperlipidemia and ameliorates glucose intolerance in Otsuka Long-Evans Tokushima Fatty (OLETF) rats.
Mori Y; Nakagiri H; Kondo H; Murase T; Tokimitsu I; Tajima N
Nutrition; 2005 Sep; 21(9):933-9. PubMed ID: 16023327
[TBL] [Abstract][Full Text] [Related]
18. Effect of inhibition of alpha-glucosidase on age-related glucose intolerance and pancreatic atrophy in rats.
Yamamoto M; Otsuki M
Metabolism; 2006 Apr; 55(4):533-40. PubMed ID: 16546485
[TBL] [Abstract][Full Text] [Related]
19. Dangnyohwan improves glucose utilization and reduces insulin resistance by increasing the adipocyte-specific GLUT4 expression in Otsuka Long-Evans Tokushima Fatty rats.
Park SY; Choi YH; Lee W
J Ethnopharmacol; 2008 Feb; 115(3):473-82. PubMed ID: 18068920
[TBL] [Abstract][Full Text] [Related]
20. Effect of timely insulin administration on pancreatic B-cells of Otsuka-Long-Evans-Tokushima-Fatty (OLETF) strain rats. An animal model of non-insulin dependent diabetes mellitus (NIDDM).
Ishida K; Mizuno A; Sano T; Noma Y; Shima K
Horm Metab Res; 1995 Sep; 27(9):398-402. PubMed ID: 8557237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
